Carolyn Bertozzi
Stanford University
Therapeutic Opportunities in Glycoscience
Monday, February 12, 8:00 PM
Pennsylvania Convention Center
Being named the 2024 Biophysical Society Lecturer is the highest annual award bestowed by the Biophysical Society. In addition to presenting the Annual Biophysical Society Lecture, the recipient provides a molecule or figure that depicts his/her research. That figure is used in the background design for that year’s Annual Meeting print and web announcements.
Carolyn Bertozzi is the Baker Family Director of Sarafan Stanford ChEM-H and the Anne T. and Robert M. Bass Professor of Humanities and Sciences in the Department of Chemistry at Stanford University. She is also an Investigator of the Howard Hughes Medical Institute. Her research focuses on profiling changes in cell surface glycosylation associated with cancer, inflammation and infection, and exploiting this information for development of diagnostic and therapeutic approaches, most recently in the area of immuno-oncology. She is an elected member of the National Academy of Medicine, the National Academy of Sciences, and the American Academy of Arts and Sciences. Most recently she was awarded the Nobel Prize in Chemistry, Wolf Prize in Chemistry, Dr. H.P. Heineken Prize for Biochemistry and Biophysics, and Welch Prize in Chemistry. She also was awarded the Lemelson-MIT Prize, a MacArthur Foundation Fellowship, the Chemistry for the Future Solvay Prize, among many others.
About the Molecule: Cell Surfaces are covered in glycosylated proteins, lipids and RNAs that mediate cell-cell interactions. This presentation will focus on development of new therapeutic modalities that target cell-surface glycans involved in cancer immune systems.